Abstract:BACKGROUND:Prostaglandin E2 receptor 3 (PTGER3, EP3) is essential for many malignancies growth and metastasis. The role of PTGER3 in kidney renal clear cell carcinoma (KIRC) was assessed in terms of its prognosis and its association with immune infiltration.METHODS:Transcriptomic expression profiles of PTGER3 were acquired from The Cancer Genome Atlas (TCGA) database. Comparative analysis was performed to evaluate the disparity in PTGER3 expression between KIRC and normal tissues. The discriminative potential of PTGER3 as a distinguishing determinant was assessed through receiver operating characteristic (ROC) curves. Prognostic factors were evaluated employing COX regression and logistic models. Furthermore, the impact of PTGER3 on survival was ascertained utilizing the Kaplan-Meier method. A protein-protein interaction (PPI) network was constructed utilizing the STRING database. To investigate the correlation between immune infiltration levels and PTGER3 expression, a single-sample Gene Set Enrichment Analysis (GSEA) method was employed, employing the Gene Set Variation Analysis (GSVA) package and the Tumor Immune Estimation Resource (TIMER) database.RESULTS:Bioinformatics analysis unveiled a significant downregulation of PTGER3 expression in KIRC tissues compared to paraneoplastic tissues (p < 0.001). Furthermore, quantitative reverse transcription polymerase chain reaction (qRT-PCR) experiments demonstrated a reduction in PTGER3 expression in 786-O cells in contrast to paraneoplastic tissues (p < 0.01). The ROC curve, employing PTGER3 as a potential diagnostic biomarker, exhibited a substantial area under the curve (AUC) value of 0.929. According to the Kaplan-Meier survival analysis, reduced PTGER3 expression increased the chance of negative overall survival (OS) (p = 0.019). A PPI network was constructed, elucidating the interaction patterns between PTGER3 and the top 10 co-expressed genes. An examination of gene enrichment and immune infiltration levels found a link between PTGER3 transcription and immune infiltration levels. Notably, high B cell counts and low Mast cell counts were connected to a poor prognosis in KIRC patients.CONCLUSIONS:The expression of PTGER3 was found to be diminished in KIRC in comparison to paracancerous tissue. This observation exhibited a correlation with both prognosis and immune cell infiltration. As a result, our findings suggest that PTGER3 could be considered a promising biomarker to forecast KIRC prognosis and as a possible target for immunotherapy.

APOBEC3G Expression Correlates with Unfavorable Prognosis and Immune Infiltration in Kidney Renal Clear Cell Carcinoma

Bioinformatics Prediction and Experimental Verification Identify CAB39L As a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.

Comprehensive Bioinformatics Analyses of APOBECs Family and Identification of APOBEC3D As the Unfavorable Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

Apobec3g Expression is Correlated with Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis

An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma

High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma

APOBEC family reshapes the immune microenvironment and therapy sensitivity in clear cell renal cell carcinoma

Upregulation of the APOBEC3 Family is Associated with a Poor Prognosis and Influences Treatment Response to Raf Inhibitors in Low Grade Glioma

Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma.

A novel defined PANoptosis-related miRNA signature for predicting prognosis and immune characteristics in Kidney Renal Clear Cell Carcinoma

Correlation of APOBEC3 in Tumor Tissues with Clinico-Pathological Features and Survival from Hepatocellular Carcinoma after Curative Hepatectomy.

Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment

Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study

APOBEC3B up-regulation independently predicts ovarian cancer prognosis: a cohort study

ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration

Aberrant APOBEC3C Expression Induces Characteristic Genomic Instability in Pancreatic Ductal Adenocarcinoma

Immunophenotyping analysis of renal cell carcinoma identified APOC1 as an immune-related biomarker and therapeutic target

Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma

TBC1D3 Family is a Prognostic Biomarker and Correlates with Immune Infiltration in Kidney Renal Clear Cell Carcinoma

Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis

Abnormal expression and prognostic significance of EPB41L1 in kidney renal clear cell carcinoma based on data mining